Welcome to THT 2023!
Now in Progress: An Immersive Experience in Latest Treatment Innovations

Building on last year’s successful inaugural Technology and Heart Failure Therapeutics conference, CRF is convening the 2nd annual THT meeting.

Registration Is Still Open

• Stay up to date.
  Get the full range of updates on the current status of drug- and device-based treatments for heart failure across the spectrum, as well as LV ejection fractions.
• Witness it here first.
  Be there for release of results of late-breaking pivotal studies that are not yet reflected in treatment guidelines.
• Catch up with colleagues from around the world.
  Take advantage of multiple opportunities for formal and informal networking.
• Return to your practice with new tools.
  Learn the latest innovations to immediately put into practice for treating heart failure.

Hear From The Program Directors

“We are in an era of unprecedented innovation and advances in drug- and device-based treatments for heart failure. THT will provide a comprehensive update from leading researchers and clinicians in the field.”

- Daniel Burkhoff, MD, PhD

“THT 2023 is a step towards changing the course of heart failure to heart recovery #success, not failure.”

- Manreet Kanwar, MD

“THT2023 is a unique forum where innovators and researchers showcase new and emerging drug and device therapeutics, and clinicians can learn and discuss exciting new opportunities to advance our care for patients with heart failure.”

- W.H. Wilson Tang, MD

Who Should Attend THT 2023?

THT 2023 is designed for a multidisciplinary audience that includes anyone interested in heart failure management and a comprehensive overview of existing and investigational interventions. This includes:

What Last Year’s Attendees Said About THT